Birmingham law firm supports company’s investment in emerging medtech leader
Shakespeare Martineau’s Birmingham office has supported engineering and manufacturing company Avingtrans plc with its £2.5m participation in a £12.9m fund raise by emerging medtech leader Adaptix.
In return for the investment and post the closing of the fund raise, Avingtrans – which designs, manufactures and supplies critical components, modules and systems to the energy, medical and industrial sectors – will own approximately 5.9% of the total issued share capital of Adaptix, which focuses on transforming radiology by allowing low-cost, low-dose 3D portable imaging.